Tehran University of Medical Sciences

Science Communicator Platform

Faculty Members have conducted research related to the Efficacy and Safety of a Proposed Omalizumab Biosimilar Compared to the Reference Product in the Management of Uncontrolled Moderate-To-Severe Allergic Asthma: A Multicenter, Phase Iii, Randomized, Double-Blind, Equivalency Clinical Trial
Besharat Rahimi
Besharat Rahimi

Associate Professor of Pulmonary Diseases

Department Internal Medicine

School of Medicine

Imam Khomeini Hospital Complex

Sleep Breathing Disorders Research Center(SBDRC)

Tehran University of Medical Sciences

All Documents